Bolt Biotherapeutics, Inc.·4

Dec 16, 1:20 PM ET

MILLER RICHARD A MD 4

4 · Bolt Biotherapeutics, Inc. · Filed Dec 16, 2022

Insider Transaction Report

Form 4
Period: 2022-12-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-14+25,00025,000 total
    Exercise: $1.36Exp: 2032-12-13Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall be fully vested upon grant date of December 14, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION